Premium
Implantation of the Melody transcatheter pulmonary valve PB1016 in patients with dysfunctional right ventricular outflow tract conduits
Author(s) -
Morray Brian H.,
Jones Thomas K.,
Coe James Y.,
Gitter Roland,
Martinez Jose Zunzunegui,
Turner Daniel R.,
Gray Robert G.,
Lung TeHsin,
Berman Darren P.,
Levi Daniel S.
Publication year - 2019
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.27974
Subject(s) - medicine , ventricular outflow tract , pulmonary valve , transesophageal echocardiogram , endocarditis , stent , cardiology , surgery , regurgitation (circulation) , balloon
Objectives This study describes procedural and 1‐year outcomes of the 16 mm Melody PB1016 valve in patients with dysfunctional RVOT conduits. Background The Melody PB1016 is a standard Melody valve produced from a 16 mm bovine jugular vein and is intended for deployment up to 20 mm. Methods This is a prospective, non‐randomized, multicenter study of the procedural and short‐term outcomes of Melody PB1016 TPV replacement within dysfunctional RVOT conduits. Data from eight centers were included in the analysis. Results During the study period, 39 patients underwent attempted Melody TPVR. Of the 39 patients, 30 underwent successful Melody TPVR. The majority of patients underwent placement of one or more stents prior to TPVR. There was a significant reduction in peak conduit pressure gradient following TPVR (38 mmHg vs. 11 mmHg, P < 0.001). There were three cases of confined conduit tears successfully treated with covered stents or the valve itself. Repeat catheterization was performed in one patient for early re‐obstruction that was successfully treated with balloon valvuloplasty. At recent follow‐up, there were no cases of more than mild valve regurgitation and the mean pulmonary valve gradient by echocardiogram remained reduced relative to pre‐TPVR implant measurements (33.5 mmHg vs. 15.2 mmHg). There were no cases of valve stent fracture or endocarditis reported at the 1‐year follow‐up. Conclusions Our analysis of TPVR with the PB1016 valve in RVOT conduits showed it to be safe and effective and can be performed in a wide range of conduit sizes with preserved valve function. ClinicalTrials.gov Identifier: NCT02347189.